Pricing infectious disease. The economic and health implications of infectious diseases

EMBO Reports

Volumn 9, Issue SUPPL. 1, 2008, Pages

  Fonkwo, Peter Ndeboc ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTHRAX; ARTICLE; AVIAN INFLUENZA; BOVINE SPONGIFORM ENCEPHALOPATHY; CHOLERA; COST CONTROL; DENGUE; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; ECONOMIC ASPECT; EPIDEMIC; FOOT AND MOUTH DISEASE; GEOGRAPHIC ORIGIN; GOVERNMENT; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HEMORRHAGIC FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; INFECTION RISK; INFLUENZA VIRUS; LIFE EXPECTANCY; MALARIA; MENINGITIS; MORTALITY; PATHOGENESIS; PLAGUE; POLIOMYELITIS; POLITICS; POPULATION MIGRATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; RESOURCE ALLOCATION; SEXUAL BEHAVIOR; SOCIOECONOMICS; SUBSTANCE ABUSE; TUBERCULOSIS; URBANIZATION; VIRUS INFECTION; YELLOW FEVER;

ANIMALS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; HUMANS; PUBLIC HEALTH; SEXUAL BEHAVIOR;

EID: 45749119100     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2008.110     Document Type: Article

References (16)

1. Alilio M (2001) International Collaboration and Malaria as a Re-Emerging Disease. Washington, DC, USA: American Association for the Advancement of Science. www.aaas.org
2. Fauci AS, Alexander DF, Paul WE (1996) Testimony on Infectious Diseases Research at NIH. Washington, DC, USA: Department of Health and Human Services. www.hhs.gov
3. Fauci AS, Touchette NA, Folkers GK (2005) Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy. and Infectious Diseases. Emerg Infect Dis 11: 519-525
4. Gallup JL, Sachs JD (2000) The Economic Burden of Malaria. Cambridge, MA, USA: Center for International Development at Harvard University. www.cid.harvard.edu
5. Gordon DF (2000) The Global Infectious Disease Threat and its Implications for the United States. Washington, DC, USA: National Intelligence Council. www.dni.gov/nic
6. Kim JY, Shakow A, Castro A, Vande C, Farmer P (2008) Tuberculosis Control. Geneva, Switzerland: World Health Organization. www.who.int
7. NIH (2008) Emerging and Re-emerging Infectious Diseases. Bethesda, MD, USA: National Institutes ofWHealth. http:/www3.niaid.nih.gov
8. Parish C, Park EC, Morens D, Saif L, Calisher C, Webster R, Burke D, Daszak P, Lacourciere K, Cassetti C (2005) Emergence of New Epidemic Viruses Through Host Switching. Bethesda, MD, USA: National Institutes of Health. www.nih.gov
9. Serwadda et al (1985) Slim disease: A new disease in Uganda and its association with HTLV-III infection. Lancet 2: 849-852
10. Stefansson H (2003) Infectious diseases and bioweapons. EMBO Rep 4: S1-S3
11. Stop TB Partnership (2006) The Global Plan to Stop TB 2006-2015: Action for Life. Geneva, Switzerland: Stop TB Partnership. www.stoptb.org/globalplan
12. UNAIDS (2006) The impact of AIDS on people and society. In 2006 Report on the Global AIDS Epidemic, pp 80-102. Geneva, Switzerland: Joint United Nation Programme on HIV/AIDS. www.unaids.org
13. Van Helden PD (2003) The economic divide and tuberculosis. EMBO Rep 4: S24-S28
14. WHO (1999) Removing Obstacles to Healthy Development. Geneva, Switzerland: World Health Organization. www.who.int
15. WHO (2003) Macro Economics and Health: The Way Forward in the African Region. Geneva, Switzerland: World Health Organization. www.who.int
16. WHO (2008) The Burden of Tuberculosis: Economic Burden. Geneva, Switzerland: World Health Organization. www.who.int